Yahoo
Stockholm - Delayed Quote SEK

Devyser Diagnostics AB (publ) (DVYSR.ST)

64.80 +3.30 (+5.37%)
At close: 5:29:54 PM GMT+1
DVYSR.ST Q3 2026 earnings call
Replay the call for the latest insights.

Key Executives

Amounts are as of December 31, 2025 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in SEK.
Name Title Pay Exercised Year Born
Mr. Jan Wahlstrom
Chief Executive Officer 2.72M -- 1967
Ms. Sabina Berlin
Chief Financial Officer -- -- 1983
Mr. Michael Uhlin Ph.D.
Chief Scientific Officer -- -- 1978
Ms. Camilla Wiberg
Chief Human Resource Officer -- -- 1979
Mr. John Murad
VP & GM of Devyser US -- -- --
Mr. Torben Tholix
Chief Commercial Officer -- -- --

Devyser Diagnostics AB (publ)

Bränningevägen 12
Årsta, 120 54
Sweden
46 8 56 21 58 50 https://devyser.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
110

Description

Devyser Diagnostics AB (publ) provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa. It offers kits and reagents, such as post-transplantation, thalassemia, fetal RHD screening NIPT, Cystic fibrosis cardiovascular diseases, male infertility, rapid aneuploidy analysis, accessories, hereditary cancer, and transfusion medicine products; and Amplicon Suite and Advyser for cloud-based software solutions for data analysis and the interpretation of test results. The company was incorporated in 2004 and is headquartered in Årsta, Sweden.

Corporate Governance

Devyser Diagnostics AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

November 3, 2026 at 4:30 PM UTC

Devyser Diagnostics AB (publ) Earnings Date

Recent Events

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: